A 15-year experience with gastric neuroendocrine tumors: Does type make a difference? - Wikidata - wikimedia - TriplyDB

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

http://www.wikidata.org/entity/Q40528641

about

Insights into gastric neuroendocrine tumors burden SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.When should genetic testing be performed in patients with neuroendocrine tumours?Hemolytic Anemia and Gastric Carcinoid in a Russian Seafarer: Highlighting the Role of Diagnostic Technologies in Modern Clinical Practice Gastric carcinoid tumor after laparoscopic gastric banding: Case report of a patient with weight regain

P2860

Q33649959-8E05CEB1-BE1D-4000-B600-55B312D288B9 Q46498642-1E21362B-1F45-4F21-94B2-48D7682410F4 Q47921456-FE8F42C0-0965-4921-B552-4312A00FE545 Q58706161-8696EC9A-B54A-4297-B884-673216256EC6 Q58764562-1290ED9F-79F8-49E1-BA43-553880F38B64

P2860

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

http://www.wikidata.org/entity/Q40528641

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

@en

type

label

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

@en

prefLabel

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

@en

P1433

Q40528641-4293592B-8120-483C-BBC4-2C621A1167A6

P1476

Q40528641-69BF4C19-F923-47B2-A751-E5309BB8B478

P2093

Q40528641-1DCFB42E-B9D4-4EA5-88F2-793AA0ACC4FB

Q40528641-39151A8E-ED28-40D6-8BA2-387B600222E8

Q40528641-3D92574F-003B-42F4-8256-E4E44DC3A1E7

Q40528641-523A8961-83A0-44BC-85A5-FA538AAA622F

Q40528641-666A7359-6E8C-49F3-905F-B9344FDCC3A8

Q40528641-71E8C8FF-04F6-4758-B2FD-225E9160E4F2

Q40528641-AE270669-0CE5-44D7-8049-8ECA8DF9A1A4

Q40528641-B4418967-4D77-45B2-9491-C981FF228183

Q40528641-DBE2AAC6-B9F3-4B70-BC11-6F12FB3772E4

Q40528641-FE3F6EF7-9F2F-4155-8EA1-89538E4FCB4B

P2860

Q40528641-186F1354-3C6F-4664-8D7B-4962C22FAB3C

Q40528641-1B1EEB4F-3870-4394-9F43-556B6C52A50E

Q40528641-21DACFF5-D4D9-425B-AEE8-AE23296AFB2B

Q40528641-2DFAC5BA-36FF-41E4-90EF-4E121803C8A2

Q40528641-2F011C87-8F48-441C-AE73-F6BBC4736C57

Q40528641-3DE37FE2-B5AF-4714-845C-31B21BE46CD5

Q40528641-401539E4-EECF-43A4-8BBD-D3CE68476F4C

Q40528641-40AF84A9-78BA-4168-A18B-E7EA9A84C6A5

Q40528641-4B9563CF-8502-4AA2-9E38-CAD85A1F3122

Q40528641-5588F6FE-7614-40B5-B593-4E24869D10F8

P304

Q40528641-01990714-9E0B-4023-BB5E-166CA4B3240D

P31

Q40528641-11AB8CA3-7BEB-41E9-9FA3-64038E0EC9BE

P356

Q40528641-ADCBEF4F-CE5E-4CB6-8408-61B172E26A05

P433

Q40528641-6DDA3011-E19E-4941-941C-074C422EBC47

P478

Q40528641-592A4A7E-9DDC-44F1-A6C8-6AB48A8B3965

P577

Q40528641-A8F4957C-6DCB-470D-A5BB-F59997D3610E

P698

Q40528641-D205AE10-3FAC-41BD-BC83-3BD5E3D7B65E

P356

P1433

Journal of Surgical Oncology

P1476

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

@en

P2093

Cecilia G Ethun

http://www.w3.org/2001/XMLSchema#string

Charles A Staley

http://www.w3.org/2001/XMLSchema#string

David A Kooby

http://www.w3.org/2001/XMLSchema#string

Field F Willingham

http://www.w3.org/2001/XMLSchema#string

Gillian G Baptiste

http://www.w3.org/2001/XMLSchema#string

Kenneth Cardona

http://www.w3.org/2001/XMLSchema#string

Lauren M Postlewait

http://www.w3.org/2001/XMLSchema#string

Maria C Russell

http://www.w3.org/2001/XMLSchema#string

Nina Le

http://www.w3.org/2001/XMLSchema#string

Shishir K Maithel

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study.

A 5-decade analysis of 13,715 carcinoid tumors.

Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature

Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment.

A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors

Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme.

Metastatic type 1 gastric carcinoid: a real threat or just a myth?

Long-term follow up of endoscopic resection for type 3 gastric NET.

Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors.

P304

576-580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24369

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27393718

http://www.w3.org/2001/XMLSchema#string